Skip to main content
UVV logo

UVV · Universal Corp /Va/

Track UVV — free
$42.83 +0.13 (+0.30%) At close · Oct 7
Market Cap
$1.06B
Shares
24.90M
Volume · Oct 7 381.78K Avg daily vol (3M) 312.36K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$42.70 Open$42.40 Day$42.25–42.83 52W close$41.65–58.77 Avg vol 30d334K Short int2.0M · 8.2% float · 6.9d Short vol69% Last earningsAug 6, 2026 DataJan 2020–Oct 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Nov 7, 2026 Est · unconfirmed · in 4 wks
filed Aug 5, 2026
call held Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$2.81B
Trailing 12 months
Net income (TTM)
$19.12M
Trailing 12 months
Revenue growth YoY
-12.2%
Year over year
Operating margin
4.9%
Trailing 12 months
P / E (TTM)
56.2
Trailing earnings · reciprocal yield 1.8%
FCF yield
15.5%
TTM · current market cap
Return on invested capital
2.0%
Trailing 12 months
Net cash
−$1.01B
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
-0.2%
Year over year · fewer shares
Price change (1Y)
-22.3%
Trailing year
Short interest
8.2%
Latest settlement · 6.9 days to cover
View all 115 metrics

AI Brief

Q1 FY27 earnings call · Aug 6, 2026
Q1 FY27

TL;DR. Universal reported a sharply weaker first quarter (operating income down 93% to $2.3M and a net loss of $5.0M) as tobacco oversupply and customer purchase delays cut tobacco segment operating income to $3.5M from $35.7M and the ingredients segment swung to a $0.7M loss, though management maintained that full-year customer demand remains consistent with its sales plan and liquidity stayed strong at ~$1.1B.

Bullish
  • + Net debt declined about $52M year-over-year to slightly over $1B, with approximately $1.1B of available liquidity.
  • + Interest expense fell $1.3M versus the prior-year quarter and is expected to be lower for the full year.
  • + Management expects no large dark air-cured inventory write-downs this year as new sales and inventory management initiatives take hold.
Bearish
  • − Consolidated operating income fell 93% to $2.3M and the company swung to a $5.0M net loss versus $8.5M of net income a year ago.
  • − Tobacco segment revenue dropped 13% and operating income fell to $3.5M from $35.7M as oversupply slowed customer buying.
  • − Ingredients segment swung to a $0.7M operating loss from $1.7M of income, with management saying tangible improvements will take time.
  • − Tobacco segment results included $4.4M of negative operating income variance from foreign currency movements.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Weak Quant / Vol Low
Market backdrop VIX 15.1 · calm Equity put/call 0.63
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −17%
below
Price vs 50-day avg −7%
below
RSI (14) 38
neutral
MACD trend Positive
52-week position 6%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −7%
trailing
6-month return −16%
trailing
YTD return −19%
this year
Relative strength −28%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $46 › 200d $52 — 200d above 50d
Institutional flow Accumulating
2 of 233 funds reported for Sep 30 · net +3.2K sh shares · +1 new
Insider flow Distributing
Net -$88.8K over 90 days · 100% sells
Short interest Rising
8.23% of float · ▲ +0.2% MoM · 6.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
233 holders — mid 3-yr range
Squeeze score 61
elevated · 0–100
Fundamentals
Weak
Revenue growth −1%
Y/Y
EPS growth −66%
Y/Y
Free cash flow $80.3M
Valuation P/E 55.9
rich
Buyback $97.0M
remaining
Balance sheet $554.5M
net debt
Quant / Vol
risk profile
Low
Volatility 24%
annualized · 1-yr
Max drawdown −29%
past year
ATR 2.2%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Feb 8, 2021
Capital expenditures (CapEx) · the next 12 months $45M – $55M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−17% Bearish
Price vs 50-day avg
−7% Bearish
RSI (14)
38 Neutral
MACD trend
Positive Bullish
52-week position
6% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $46 › 200d $52 — 200d above 50d
Institutional flow Accumulating
2 of 233 funds reported for Sep 30 · net +3.2K sh shares · +1 new
Insider flow Distributing
Net -$88.8K over 90 days · 100% sells
Short interest Rising
8.23% of float · ▲ +0.2% MoM · 6.9 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
233 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $42 Now $43 · 6% Range high $59
vs 200-day avg -17% vs 50-day avg -7%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Available liquidity $1.1B as of June 30, 2026 —
Gross profit margin percentage 15.9% Three Months Ended June 30, 2026 —
Net Capitalization non-GAAP $2.4B as of June 30, 2026 —
Net Debt non-GAAP $1.01B as of June 30, 2026 —
Net Debt/Net Capitalization non-GAAP 42% as of June 30, 2026 —
Tobacco sales prices 6% Three Months Ended June 30, 2026 —
Tobacco sales volumes 9% Three Months Ended June 30, 2026 —
Uncommitted tobacco inventory levels 24% as of June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Tobacco — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
UVV
Universal Corp /Va/
this stock
$1.06B -19.1% -1.3% 55.9 8.2%
PM
Philip Morris International Inc.
$296.88B +18.7% +7.3% 27.4 0.9%
BTI
British American Tobacco p.l.c.
$118.02B -6.4% — — 0.1%
MO
Altria Group, Inc.
$115.85B +18.9% -3.1% 14.6 2.3%
RLX
RLX Technology Inc.
$2.05B -27.0% +50.3% — 0.8%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
234
% held
82.1%
Reported
2 of 233
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
250
View
Short & Settlement
Short Interest Rising
Shares short
2.0M
Days to cover
6.9d
Change
+3.7K sh
View
Short Volume
Short vol %
69%
As of
Oct 7, 2026
Short Total
View
Fails to Deliver
FTD shares
1.2K
Value
$52.0K
As of
Sep 14, 2026
View
Off-Exchange
Off-exchange %
46.2%
Week of
Aug 31, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$88.8K
Buyers / Sellers
0 / 1
Buyers Sellers
View
Congressional Trades Sell
Member
Virginia Foxx
Amount
$15.0K–$50.0K
Traded
Jul 14, 2022
View
Financials
Financials
Revenue (FY)
$2.9B
Net income (FY)
$32.6M
EPS diluted
$1.30
View
Buybacks
Authorized
$100.0M
Remaining
$97.0M
Spent Remaining
View
Filings
SEC Filings
Latest
8-K
Filed
Sep 18, 2026
This year
12
View
Proposed Sales
Value
$88.8K
Shares
1.8K
Filed
Aug 10, 2026
View
Earnings & Events
Webcasts
Last webcast
Aug 6, 2026
View
Investor Relations
Latest news
Universal Corporation Reports Fir…
Published
Aug 5, 2026
View

Performance

5D 20D 120D MTD YTD
UVV +2.5% -6.5% -16.3% +2.2% -19.1%
SPY +2.0% +1.7% +11.3% +2.2% +14.3%
vs SPY +0.6% -8.3% -27.6% +0.0% -33.3%

Capital returns

Latest dividend
$0.83 / share · ex Jul 13, 2026
Declared · upcoming
$0.83 / share · ex Oct 9, 2026
Raised 1.2%
Paid (TTM)
$3.29 / share · 4 payouts
Dividend yield (TTM, derived)
7.70%
Buyback program · as of Jun 30, 2026
Authorized
$100.00M
Spent (derived)
$3.00M
Remaining
$97.00M
Spent Remaining

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 102037 CUSIP 913456109 13F (30d) 4 filings 4 filers Visit website Investor relations